A Duke University School of Medicine team reimagines a sci-fi classic as real-world biotech that can speed up biological research.

An epic collaboration between neuroscientists at Duke and six other institutions has yielded an AI tool that paves the way for new approaches to treating neurological disorders.

New strategy could change how we design drugs—especially the large and polar ones that were once too big to work.

Researchers propose a "treatable fetal findings list" that identifies genetic conditions that can be detected with prenatal testing and treated in utero or in the first week of life.